Paul Hudson, Sanofi CEO (Getty Images)
Sanofi prunes its pipeline, taking the ax to a lineup of drug, vaccine programs
Sanofi swept away a lineup of drug and vaccine programs in its Q2 update, starting with a late-stage vaccine play with Daiichi Sankyo and running …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
